About QSI
QSI is a Healthcare company based in Chandigarh (India) founded in 2004, and was acquired by Parexel in March 2015. Pharmacovigilance services are offered by Quantum Solutions as a CRO. Its focus areas include Biopharma Outsourcing, Consulting and Regulatory Affairs. Its legal entity in India is Quantum Solutions Private Limited (U33125KA1976PTC002980).
Company details
Quantum Solutions India was established in 2004 in Chandigarh, India, as a contract research organization focused on pharmacovigilance. Services provided include drug safety monitoring, medical writing, clinical summaries, product feasibility reports for medical devices, and literature search reviews. Operations cover therapeutic areas such as oncology, infections, dermatology, cardiovascular conditions, ophthalmology, rheumatology, and immunologyautoimmune diseases. As of 2015, it has been operated as a subsidiary of Parexel International Corporation.
- Headquarters Chandigarh, India
- Stage Acquired
- SectorsHealthcare
- Website qsi.in
- Social LinkedIn X
- Acquired by Parexel (Mar 2015)
- Legal Name Quantum Solutions Private Limited
- Date of Incorporation 03 Apr, 1976
- Jurisdiction Bangalore, Karnataka, India
Associated legal entities of QSI
QSI operates through Quantum Solutions Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Quantum Solutions Private Limited CIN U33125KA1976PTC002980 | Active | 03 Apr 1976 | Bangalore, Karnataka | 2 | View details |
Investors in QSI
QSI has secured backing from 1 investor. Prominent investors backing the company include Parexel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Full-service clinical research organization services are provided globally by Parexel. | 1983 | parexel.com | Waltham, United States |
Investor details for QSI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Quantum Solutions Private Limited (QSI)
Quantum Solutions Private Limited is the primary company behind QSI. The board of Quantum Solutions Private Limited currently have 2 directors; the longest-serving is Sakhamuri Geeta Ramani, appointed in 2006. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sakhamuri Geeta Ramani DIN 00905012 | Director | 28 Aug 2006 | 20 yrs 1 mo | Quantum Solutions Private Limited |
| Sakhamuri Padmaja DIN 00905036 | Director | 28 Aug 2006 | 20 yrs 1 mo | Quantum Solutions Private Limited |
People of QSI
7 people are tracked at QSI (3 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Rohit Seth | Managing Director | Leadership |
Nikhila Sharma | Chief Pahrmacovigilnace Scientist | Leadership |
Simran Singh | Chief Pharmacovigilance Specialist | Leadership |
Kanika Mahajan | Pharmacovigilance Specialist | Team |
Manleen Narula | Pharmacovigilance Scientist | Team |
Chirag Dhingra | Pharmacovigilanc Specilist | Team |
Shruchi Tanwar | PV Scientist | Team |
Complete people profiles for QSI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of QSI
Figures of Quantum Solutions Private Limited, the primary company behind QSI, for FY 2023. Net loss was -₹43,959 (0% margin). EBITDA was -₹19,875 (0% margin). Revenue has grown at a compounded annual rate of -100% over three years and -100% over five years.
- -₹43,959Net loss · 0% margin
- -₹19,875EBITDA · 0% margin
- ₹1 LakhPaid-up capital
- -100%Revenue CAGR, 3 years
- -100%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Quantum Solutions Private Limited are on its company page.
Detailed financial statements for QSI
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of QSI
2 dated milestones of QSI across 11 years, from founding to its latest funding, stage changes and deals.
- Founded QSI is founded.
- Exit Acquired by Parexel.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as QSI (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about QSI
QSI was founded in 2004.
QSI is headquartered in Chandigarh, India.
Quantum Solutions India was established in 2004 in Chandigarh, India, as a contract research organization focused on pharmacovigilance. Services provided include drug safety monitoring, medical writing, clinical summaries, product feasibility reports for medical devices, and literature search reviews. Operations cover therapeutic areas such as oncology, infections, dermatology, cardiovascular conditions, ophthalmology, rheumatology, and immunologyautoimmune diseases. As of 2015, it has been operated as a subsidiary of Parexel International Corporation.
QSI has 1 investor. Key investors include Parexel.
QSI operates through Quantum Solutions Private Limited.
Yes. QSI was acquired by Parexel in March 2015.
The legal entities of QSI currently have 2 directors, including Sakhamuri Geeta Ramani, Sakhamuri Padmaja.